STOCK TITAN
  1. Home
  2. SRNE

Sorrento Therapeutics Stock Price, News & Analysis

SRNE OTC

Company Description

Welcome to the overview page for Sorrento Therapeutics (SRNE), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

Chart
$0.0021
0.00%
0.00
Last updated: June 14, 2025 at 15:45
- %
Performance 1 year
$385.9K
Market Cap
551.3M
Shares outstanding

Latest News

View All
June 5, 2023
7.35%

Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the ASCO 2023 Meeting

February 21, 2023
20.26%

Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case

February 19, 2023
24.32%

Sorrento Posts Form 8937 to Supplement its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)

dividends
February 17, 2023
20.20%

Sorrento Issues Update to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)

dividends
February 16, 2023
56.11%

Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management Motions

February 16, 2023
56.11%

Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management Motions

SEC Filings

View All

No SEC filings available for Sorrento Therapeutics.

Financial Highlights

—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Sorrento Therapeutics (SRNE)?

The current stock price of Sorrento Therapeutics (SRNE) is $0.0021 as of June 13, 2025.

What is the market cap of Sorrento Therapeutics (SRNE)?

The market cap of Sorrento Therapeutics (SRNE) is approximately 385.9K.